Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6243-6249

  Marra, Fawziah ^a,b   Patrick, David M ^a,b   Chong, Mei ^b   McKay, Rachel ^b   Hoang, Linda ^a,b   Bowie, William R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE;

ARTICLE; HEALTH CARE UTILIZATION; HUMAN; INCISION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTPATIENT; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRITISH COLUMBIA; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; POPULATION; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; YOUNG ADULT;

EID: 84869216036     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00649-12     Document Type: Article

References (40)

1. Al-Rawahi GN, et al. 2010. Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital. J. Emerg. Med. 38:6-11.
2. Al-Rawahi GN, et al. 2008. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J. Clin. Microbiol. 46:477-479.
3. Baggett HC, et al. 2003. An outbreak of community-onset methicillin resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect. Control Hosp. Epidemiol. 24:397-402.
4. Barber M. 1947. Staphylococcal infection due to penicillin-resistant strains. Br. Med. J. ii:863-865.
5. Barber M. 1961. Methicillin-resistant staphylococci. J. Clin. Pathol. 14:385-393.
6. BC Centre for Disease Control. 2012. Antimicrobial resistance trends in the province of British Columbia: 2011. Communicable Disease Prevention Services, BCCDC, Vancouver, British Columbia, Canada. http://www.bccdc.ca/ prevention/AntibioticResistance. Accessed 6 June 2012.
7. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. 2002. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med. 162:2229-2235.
8. Boyce JM. 1990. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect. Control Hosp. Epidemiol. 11:639-642.
9. Chua K, Howden BP. 2009. Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics. Curr. Opin. Infect. Dis. 22:525-534.
10. Dalager-Pedersen M, Søgaard M, Schønheyder HC. 2011. Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year population-based study. Eur. J. Clin. Microbiol. Infect. Dis. 30:951-956.
11. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Community-associated methicillin-resistant Staphylococcus aureus. Lancet 375:1557-1568.
12. Diep BA, et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739.
13. Embil J, et al. 1994. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect. Control Hosp. Epidemiol. 15:646-651.
14. Fergie JE, Purcell K. 2001. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr. Infect. Dis. J. 20:860-863.
15. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. 2010. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J. Pediatr. Surg. 45:1967-1974.
16. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. 2009. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin. Infect. Dis. 49:65-71.
17. Golding GR, et al. 2011. High rates of Staphylococcus aureus USA400 infection, Northern Canada. Emerg. Infect. Dis. 17:722-725.
18. Hanberger H, et al. 2011. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int. J. Antimicrob. Agents 38:331-335.
19. Hersh AL, Chambers HF, Maselli JH, Gonzales R. 2008. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch. Intern. Med. 168:1585-1591.
20. Hussain FM, Boyle-Vavra S, Daum RS. 2001. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr. Infect. Dis. J. 20:763-767.
21. Reference deleted.
22. Karamatsu ML, Thorp AW, Brown L. 2012. Changes in community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections presenting to the pediatric emergency department: comparing 2003 to 2008. Pediatr. Emerg. Care 28:131-135.
23. Lautz TB, Raval MV, Barsness KA. 2011. Increasing national burden of hospitalizations for skin and soft tissue infections in children. J. Pediatr. Surg. 46:1935-1941.
24. Liu C, et al. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52:285-292.
25. Lloyd-Smith E, et al. 2011. Screening for methicillin-resistant Staphylococcus aureus (MRSA) in community-recruited injection drug users: are throat swabs necessary? Epidemiol. Infect. 13:1721-1724.
26. Matlow A, et al. 2012. National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995-2007. Pediatr. Infect. Dis. J. 31:814-820.
27. McCaig LF, McDonald LC, Mandal S, Jernigan DB. 2006. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg. Infect. Dis. 12:1715-1723.
28. McDougal LK, et al. 2010. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob. Agents Chemother. 54:3804-3811.
29. Moellering RC, Jr. 2012. MRSA: the first half century. J. Antimicrob. Chemother. 67:4-11.
30. Mulvey MR, et al. 2005. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg. Infect. Dis. 11:844-850.
31. Naimi TS, et al. 2003. Comparison of community and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
32. Nichol KA, et al. 2011. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study. Diagn. Microbiol. Infect. Dis. 69:320-325.
33. Nichol KA, et al. 2009. Comparison of community-associated and healthcare associated methicillin-resistant Staphylococcus aureus in Canada: results from CANWARD. Can. J. Infect. Dis. Med. Microbiol. 20(Suppl A):31-36.
34. Pallin DJ, et al. 2008. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann. Emerg. Med. 51:291-298.
35. Robicsek A, et al. 2008. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med. 148:409-418.
36. Simor AE, et al. 2010. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance of changing epidemiology, 1995-2007. Infect. Control Hosp. Epidemiol. 31:348-356.
37. Simor AE, et al. 2010. Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008. Antimicrob. Agents Chemother. 54:2265-2268.
38. Tenover FC, et al. 2008. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J. Clin. Microbiol. 46:2837-2841.
39. Udo EE, Pearman JW, Grubb WB. 1993. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25:97-108.
40. Witte W, Kresken M, Braulke C, Cuny C. 1997. Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin. Microbiol. Infect. 3:414-422.